Incidence and Risk Factors for Glucose Disturbances in Premature Infants

Ivona Butorac Ahel1,2, Kristina Lah Tomulić2,3, Inge Vlašić Cicvarić2,4

  • 1Department of Pediatrics, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia.

Medicina (Kaunas, Lithuania)
|September 23, 2022
PubMed

Insights

Glucose disturbances like hypoglycemia and hyperglycemia are common in preterm infants during their first week. Careful monitoring is crucial, especially for late preterm infants, to prevent neurological issues.

Area of Science:

  • Neonatology
  • Endocrinology
  • Pediatrics

Background:

  • Limited data exists on glucose dysregulation incidence and risk factors in preterm infants.
  • Neonatal hypoglycemia, hyperglycemia, and unstable glycemia pose risks to preterm infants.

Purpose of the Study:

  • To determine the incidence of neonatal hypoglycemia, hyperglycemia, and unstable glycemia in preterm infants.
  • To identify risk factors associated with these glucose disturbances within the first seven days of life.

Main Methods:

  • Prospective study of preterm infants (<37 weeks gestation) admitted to NICU from 2018-2020.
  • Categorization into normoglycemic, hypoglycemic, hyperglycemic, and unstable groups based on blood glucose levels.
  • Blood glucose monitoring at multiple time points in the first week of life.

Main Results:

  • Incidence: 20.7% hypoglycemia, 9.9% hyperglycemia, 2.9% unstable glycemia.
  • Hypoglycemia common in infants ≥34 weeks; hyperglycemia common in infants <28 weeks.
  • Risk factors: Female gender (hypoglycemia), decreased gestational age, sepsis, respiratory distress syndrome, mechanical ventilation (hyperglycemia).

Conclusions:

  • Glucose disturbances are frequent in early neonatal period preterm infants and often asymptomatic.
  • Close blood glucose monitoring is essential, particularly in late preterm infants.
  • Monitoring helps prevent potential neurological complications associated with neonatal glycemia issues.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
315
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
225
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
662